Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate

Patent 11559501 was granted and assigned to Noven Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo